Hemangiopericytoma - 25 Studies Found
Recruiting |
: Proton Radiation For Meningiomas and Hemangiopericytomas : Patients With a Diagnosis of WHO Grade I-III Meningioma and Hemangiopericytoma With Adequate Bone Marrow Function : 2010-04-28 : Radiation: Proton Radiation Prons has been demonstrated for medulloblastoma and prostate cancer, and com |
Not yet recruiting |
: A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma :
|
Completed |
: Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma :
|
Active, not recruiting |
: Trial of Dasatinib in Advanced Sarcomas :
|
Completed |
: Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma :
|
Not yet recruiting |
: Phase II Pediatric Study With Dabrafenib in HGG Patients :
|
Completed |
: Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 :
|
Terminated |
: S9624 Ifosfamide in Treating Patients With Meningeal Tumors :
: Drug: ifosfamide |
Active, not recruiting |
: Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas :
|